Cost-effectiveness of second-generation antipsychotics for the treatment of schizophrenia

MLA

Karen M. Kuntz, and T. Park. “Cost-Effectiveness of Second-Generation Antipsychotics for the Treatment of Schizophrenia.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 17, no. 4, July 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1a91a3f32ff366343d1a9b55a5c7852&authtype=sso&custid=ns315887.

APA

Karen M. Kuntz, & T. Park. (2013). Cost-effectiveness of second-generation antipsychotics for the treatment of schizophrenia. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(4).

Chicago

Karen M. Kuntz, and T. Park. 2013. “Cost-Effectiveness of Second-Generation Antipsychotics for the Treatment of Schizophrenia.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 17 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1a91a3f32ff366343d1a9b55a5c7852&authtype=sso&custid=ns315887.